Page last updated: 2024-08-23

azoxymethane and nicotine

azoxymethane has been researched along with nicotine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hamada, T; Hayashi, S; Ishii, Y; Kadowaki, M; Lee, J; Oshiro, M; Sasahara, M; Yamamoto, T; Zaidi, SF	1

Other Studies

1 other study(ies) available for azoxymethane and nicotine

Article	Year
Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice. American journal of physiology. Gastrointestinal and liver physiology, 2014, Nov-15, Volume: 307, Issue:10 Topics: Acute Disease; alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Azoxymethane; CD4-Positive T-Lymphocytes; Chronic Disease; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Disease Models, Animal; Down-Regulation; Gastrointestinal Agents; Inflammation Mediators; Interleukin-6; Intestinal Mucosa; Male; Mice, Inbred BALB C; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; RNA, Messenger; Severity of Illness Index; STAT3 Transcription Factor; Time Factors; Tumor Necrosis Factor-alpha	2014

Article

Year

Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice.

American journal of physiology. Gastrointestinal and liver physiology, 2014, Nov-15, Volume: 307, Issue:10

Topics: Acute Disease; alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Azoxymethane; CD4-Positive T-Lymphocytes; Chronic Disease; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Disease Models, Animal; Down-Regulation; Gastrointestinal Agents; Inflammation Mediators; Interleukin-6; Intestinal Mucosa; Male; Mice, Inbred BALB C; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; RNA, Messenger; Severity of Illness Index; STAT3 Transcription Factor; Time Factors; Tumor Necrosis Factor-alpha

2014